GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (NYSE:PFE) » Definitions » Shiller PE Ratio

Pfizer (Pfizer) Shiller PE Ratio

: 9.35 (As of Today)
View and export this data going back to 1951. Start your Free Trial

As of today (2024-04-18), Pfizer's current share price is $25.42. Pfizer's E10 for the quarter that ended in Dec. 2023 was $2.72. Pfizer's Shiller PE Ratio for today is 9.35.

The historical rank and industry rank for Pfizer's Shiller PE Ratio or its related term are showing as below:

PFE' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.29   Med: 17.48   Max: 24.28
Current: 9.35

During the past years, Pfizer's highest Shiller PE Ratio was 24.28. The lowest was 9.29. And the median was 17.48.

PFE's Shiller PE Ratio is ranked better than
89.71% of 515 companies
in the Drug Manufacturers industry
Industry Median: 24.57 vs PFE: 9.35

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.600. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $2.72 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pfizer Shiller PE Ratio Historical Data

The historical data trend for Pfizer's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.89 17.21 23.38 17.14 10.60

Pfizer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.14 13.21 12.63 11.69 10.60

Competitive Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.



Pfizer Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=25.42/2.72
=9.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Pfizer's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.6/129.4194*129.4194
=-0.600

Current CPI (Dec. 2023) = 129.4194.

Pfizer Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.360 99.695 0.467
201406 0.450 100.560 0.579
201409 0.420 100.428 0.541
201412 0.190 99.070 0.248
201503 0.380 99.621 0.494
201506 0.420 100.684 0.540
201509 0.340 100.392 0.438
201512 -0.030 99.792 -0.039
201603 0.490 100.470 0.631
201606 0.330 101.688 0.420
201609 0.220 101.861 0.280
201612 0.130 101.863 0.165
201703 0.510 102.862 0.642
201706 0.510 103.349 0.639
201709 0.470 104.136 0.584
201712 2.020 104.011 2.513
201803 0.590 105.290 0.725
201806 0.650 106.317 0.791
201809 0.690 106.507 0.838
201812 -0.070 105.998 -0.085
201903 0.680 107.251 0.821
201906 0.890 108.070 1.066
201909 1.360 108.329 1.625
201912 -0.060 108.420 -0.072
202003 0.600 108.902 0.713
202006 0.620 108.767 0.738
202009 0.260 109.815 0.306
202012 0.100 109.897 0.118
202103 0.860 111.754 0.996
202106 0.980 114.631 1.106
202109 1.420 115.734 1.588
202112 0.590 117.630 0.649
202203 1.370 121.301 1.462
202206 1.730 125.017 1.791
202209 1.510 125.227 1.561
202212 0.870 125.222 0.899
202303 0.970 127.348 0.986
202306 0.410 128.729 0.412
202309 -0.420 129.860 -0.419
202312 -0.600 129.419 -0.600

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pfizer  (NYSE:PFE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pfizer Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (Pfizer) Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Executives
Scott Gottlieb director MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Christoffel Boshoff officer: Executive Vice President 66 HUDSON BOULEVARD EAST, NEW YORK NY 10001-2192
Jennifer B. Damico officer: SVP & Controller C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Payal Sahni officer: Executive Vice President ATTN: PFIZER CORP. SECRETARY, 235 EAST 42ND ST., NEW YORK NY 10017
Carapezzi William R Jr officer: Executive Vice President 600 MOUNTAIN AVENUE, MURRAY HILL NJ 07921
Douglas M Lankler officer: Senior Vice President PFIZER INC. ATTN: CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Mikael Dolsten officer: Senior Vice President 5 GIRALDA FARMS, MADISON NJ 07940
David M Denton officer: Chief Financial Officer & EVP 1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117
William Pao officer: Executive Vice President C/O CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Michael Mcdermott officer: Executive Vice President C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, 235 EAST 42ND STREET NY 10017
Rady A Johnson officer: Executive Vice President PFIZER INC. ATTN CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Alexander R Mackenzie officer: Executive Vice President C/O PFIZER CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Sally Susman officer: Senior Vice President 767 FIFTH AVE, EOTIC LAWDER CORP, NEW YORK NY 10153
Angela Hwang officer: Group President 235 EAST 42ND STREET, ATTN: CORPORATE SECRETARY, NEW YORK NY 10017
John D Young officer: Business Unit President C/O CORPORATE SECRETARY, 235 EAST 42ND ST., NEW YORK NY 10017

Pfizer (Pfizer) Headlines

From GuruFocus

Q3 2022 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Citi BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc's Dividend Analysis

By GuruFocus Research 01-24-2024

Pfizer Inc at Cowen Health Care Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc to Review Oral GLP-1 Data Call Transcript

By GuruFocus Research 01-23-2024